Inactivating mutations in the CLCNKB gene (encoding ClC-Kb, human version of ClC-K2) underlie Bartter’s syndrome type III associated with hypotension, hypochloremia, and metabolic alkalosis (40, 41, 42). This evidence concerns the gene CLCNKB and Bartter disease type 3.